Varban Ganev

596 total citations
28 papers, 480 citations indexed

About

Varban Ganev is a scholar working on Genetics, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Varban Ganev has authored 28 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 9 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Varban Ganev's work include Nephrotoxicity and Medicinal Plants (7 papers), BRCA gene mutations in cancer (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Varban Ganev is often cited by papers focused on Nephrotoxicity and Medicinal Plants (7 papers), BRCA gene mutations in cancer (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Varban Ganev collaborates with scholars based in Bulgaria, United States and Germany. Varban Ganev's co-authors include Anélia Horvath, Evangelos Petropoulos, Arseni Markoff, Nadia Bogdanova, James E. Trosko, Brad L. Upham, Thomas C. Voice, Shawn P. McElmurry, David T. Long and Ivo Kremensky and has published in prestigious journals such as Environmental Pollution, Clinical Chemistry and Life Sciences.

In The Last Decade

Varban Ganev

27 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Varban Ganev Bulgaria 13 125 122 119 71 59 28 480
Yan Yi China 15 143 1.1× 135 1.1× 40 0.3× 72 1.0× 26 0.4× 56 711
Guiqin Li China 11 182 1.5× 34 0.3× 53 0.4× 65 0.9× 9 0.2× 33 358
Hidetaka Sumiyoshi Japan 10 233 1.9× 44 0.4× 192 1.6× 39 0.5× 25 0.4× 19 577
Flávia de Holanda Schmidt Germany 11 335 2.7× 39 0.3× 71 0.6× 94 1.3× 67 1.1× 25 867
Dilip D. Vakharia United States 14 213 1.7× 33 0.3× 25 0.2× 78 1.1× 97 1.6× 26 744
John R. Henneman United States 14 188 1.5× 21 0.2× 43 0.4× 103 1.5× 49 0.8× 31 655
Henglei Lu China 12 194 1.6× 41 0.3× 22 0.2× 87 1.2× 11 0.2× 20 429
Jeanette Wiltse United States 6 125 1.0× 19 0.2× 77 0.6× 58 0.8× 37 0.6× 7 568
Gregory Akerman United States 7 154 1.2× 28 0.2× 42 0.4× 13 0.2× 21 0.4× 10 426

Countries citing papers authored by Varban Ganev

Since Specialization
Citations

This map shows the geographic impact of Varban Ganev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Varban Ganev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Varban Ganev more than expected).

Fields of papers citing papers by Varban Ganev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Varban Ganev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Varban Ganev. The network helps show where Varban Ganev may publish in the future.

Co-authorship network of co-authors of Varban Ganev

This figure shows the co-authorship network connecting the top 25 collaborators of Varban Ganev. A scholar is included among the top collaborators of Varban Ganev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Varban Ganev. Varban Ganev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Justenhoven, Christina, Stefan Winter, Ute Hamann, et al.. (2009). No evidence for glutathione S-transferases GSTA2, GSTM2, GSTO1, GSTO2, and GSTZ1 in breast cancer risk. Breast Cancer Research and Treatment. 121(2). 497–502. 29 indexed citations
2.
Ganev, Varban, et al.. (2007). Genetic Bases for Predisposition to Common Multifactorial Disease in Man. Part II. Biotechnology & Biotechnological Equipment. 21(4). 385–392. 1 indexed citations
3.
Eap, Chin B., et al.. (2007). Pharmacogenetics of acenocoumarol: CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5 and ABCB1 gene polymorphisms and dose requirements. Journal of Clinical Pharmacy and Therapeutics. 32(6). 641–649. 32 indexed citations
4.
Voice, Thomas C., David T. Long, Zoran Radovanović, et al.. (2006). Critical Evaluation of Environmental Exposure Agents Suspected in the Etiology of Balkan Endemic Nephropathy. International Journal of Occupational and Environmental Health. 12(4). 369–376. 30 indexed citations
5.
Voice, Thomas C., et al.. (2006). Evaluation of the hypothesis that Balkan endemic nephropathy is caused by drinking water exposure to contaminants leaching from Pliocene coal deposits. Journal of Exposure Science & Environmental Epidemiology. 16(6). 515–524. 21 indexed citations
6.
Horvath, Anélia, et al.. (2004). Balkan endemic nephropathy and genetic variants of glutathione S-transferases. Journal of Nephrology. 17(3). 390–398. 24 indexed citations
7.
Horvath, Anélia, et al.. (2004). Screening for point mutations in the LDL receptor gene in Bulgarian patients with severe hypercholesterolemia. Journal of Human Genetics. 49(4). 173–176. 11 indexed citations
8.
McElmurry, Shawn P., Thomas C. Voice, David T. Long, et al.. (2004). Nitrogen species in drinking water indicate potential exposure pathway for Balkan Endemic Nephropathy. Environmental Pollution. 134(2). 229–237. 17 indexed citations
9.
Horvath, Anélia, et al.. (2003). Five Polymorphisms of the Apolipoprotein B Gene in Healthy Bulgarians. Human Biology. 75(1). 69–80. 10 indexed citations
10.
Voice, Thomas C., et al.. (2002). Evaluation of coal leachate contamination of water supplies as a hypothesis for the occurrence of Balkan endemic nephropathy in Bulgaria. 81(8). 342–4. 6 indexed citations
11.
Horvath, Anélia, Brad L. Upham, Varban Ganev, & James E. Trosko. (2002). Determination of the epigenetic effects of ochratoxin in a human kidney and a rat liver epithelial cell line. Toxicon. 40(3). 273–282. 48 indexed citations
12.
Abouzied, Mekky M., et al.. (2002). Ochratoxin A concentrations in food and feed from a region with Balkan Endemic Nephropathy. Food Additives & Contaminants. 19(8). 755–764. 66 indexed citations
13.
Ganev, Varban, et al.. (2002). Is the incidence of Balkan endemic nephropathy decreasing?. Pathologie Biologie. 50(1). 38–41. 29 indexed citations
14.
Long, David T., Gary A. Icopini, Varban Ganev, et al.. (2001). Geochemistry of Bulgarian soils in villages affected and not affected by Balkan endemic nephropathy: a pilot study.. PubMed. 14(2). 193–6. 12 indexed citations
15.
Boyanovsky, Boris B., et al.. (2001). Prevalence of factor V Leiden and prothrombin 20210 A variant in Bulgarian patients with pulmonary thromboembolism and deep venous thrombosis. Blood Coagulation & Fibrinolysis. 12(8). 639–642. 16 indexed citations
16.
Dobreva, Gergana, et al.. (2000). Protein C Activity in Patients with Antiphospholipid Syndrome. JCR Journal of Clinical Rheumatology. 6(5). 239–243. 9 indexed citations
17.
Ganev, Varban, et al.. (2000). Morphine treatment affects the regulation of high mobility group I-type chromosomal phosphoproteevs in C6 glioma cells. Life Sciences. 66(18). 1725–1731. 10 indexed citations
18.
Kremensky, Ivo, et al.. (1999). A simple method for detection of factor V R506Q (Leiden) mutation in dried blood spots. Clinica Chimica Acta. 284(1). 89–92. 5 indexed citations
19.
Ganev, Varban, et al.. (1988). Selective immunodeficiency with defect in interferon‐gamma induction in two sibs with recurrent infections. Clinical Genetics. 33(6). 454–456. 2 indexed citations
20.
Mičić, S., et al.. (1987). Cytogenetic Analysis of Men with Cryptorchidism and Reduced Fertility. Urologia Internationalis. 42(1). 58–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yan Yi Breakdown of academic impact, for papers by Guiqin Li Breakdown of academic impact, for papers by Hidetaka Sumiyoshi Breakdown of academic impact, for papers by Flávia de Holanda Schmidt Breakdown of academic impact, for papers by Dilip D. Vakharia Breakdown of academic impact, for papers by John R. Henneman Breakdown of academic impact, for papers by Henglei Lu Breakdown of academic impact, for papers by Jeanette Wiltse Breakdown of academic impact, for papers by Gregory Akerman
Rankless by CCL
2026